TABLE OF CONTENTS
1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 OVERVIEW OF THE GLOBAL UROLOGY LASER MARKET 17
1.4 CURRENCY AND PRICING 19
1.5 LIMITATIONS 19
1.6 MARKETS COVERED 19
2 MARKET SEGMENTATION 23
2.1 MARKETS COVERED 23
2.2 GEOGRAPHICAL SCOPE 24
2.3 YEARS CONSIDERED FOR THE STUDY 25
2.4 DBMR TRIPOD DATA VALIDATION MODEL 26
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
2.6 MULTIVARIATE MODELLING 30
2.7 PRODUCT TYPE LIFELINE CURVE 30
2.8 DBMR MARKET POSITION GRID 31
2.9 VENDOR SHARE ANALYSIS 33
2.10 MARKET END USER COVERAGE GRID 34
2.11 SECONDARY SOURCES 35
2.12 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHT 39
4.1 PESTEL ANALYSIS 41
4.2 PORTERS FIVE FORCES 42
4.3 IMPORT-EXPORT ANALYSIS 43
4.3.1 IMPORT 43
4.3.1.1 INDIA 43
4.3.2 EXPORT 43
4.4 STRATEGIC INITIATIVES 44
4.5 PRICING ANALYSIS 45
4.6 ADOPTION OF LASER 45
5 GLOBAL UROLOGY LASER MARKET, EPIDEMIOLOGY 47
5.1 INCIDENCE AND PREVALENCE OF UROLOGY DISORDERS, BY COUNTRY 47
5.2 UROLITHIASIS 47
5.3 BENIGN PROSTATIC HYPERPLASIA (BPH) 48
5.4 PARTIAL KIDNEY RESECTION 50
5.5 KIDNEY STONES 50
5.6 URETHRAL STRICTURES 51
5.7 TUMORS 51
6 GLOBAL UROLOGY LASER MARKET, REGULATIONS 52
6.1 REGULATORY SCENARIO IN THE U.S. 52
6.2 REGULATORY SCENARIO IN AUSTRALIA 52
6.3 REGULATORY SCENARIO IN INDIA 53
6.4 REGULATORY SCENARIO IN U.K. 54
7 MARKET OVERVIEW 55
7.1 DRIVERS 57
7.1.1 RISING NUMBER OF PATIENTS RELATED TO UROLOGY DISORDERS GLOBALLY 57
7.1.2 INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES 57
7.1.3 RISE IN THE NUMBER OF PRODUCT APPROVAL FOR LASER DEVICES 57
7.1.4 RISING RESEARCH AND DEVELOPMENT ACTIVITIES FOR UROLOGY LASER DEVICES 58
7.2 RESTRAINTS 59
7.2.1 HIGH COST OF UROLOGY LASER DEVICE AND PROCEDURE 59
7.2.2 SAFETY CONCERNS AND ADVERSE EFFECTS ASSOCIATED WITH LASER PROCEDURES SAFETY CONCERNS 59
7.2.3 LACK OF AWARENESS ABOUT TREATMENT FOR UROLOGICAL CONDITIONS 59
7.3 OPPORTUNITIES 60
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN LASER TECHNOLOGY 60
7.3.2 STRATEGIC INITIATIVES BY EMERGING PLAYERS 61
7.4 CHALLENGES 61
7.4.1 LACK OF SKILLED PROFESSIONALS 61
7.4.2 STRINGENT REGULATIONS 62
8 GLOBAL UROLOGY LASER MARKET, BY LASER TYPE 63
8.1 OVERVIEW 64
8.2 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 67
8.3 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 67
8.4 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 68
8.5 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 68
8.6 DIODE LASER 69
8.7 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 69
8.8 LITHIUM BORATE 70
8.9 OTHERS 70
9 GLOBAL UROLOGY LASER MARKET, BY MODALITY 71
9.1 OVERVIEW 72
9.2 PORTABLE 75
9.3 STANDALONE 75
10 GLOBAL UROLOGY LASER MARKET, BY APPLICATION 76
10.1 OVERVIEW 77
10.2 UROLITHIASIS 80
10.2.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 80
10.2.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 81
10.2.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 81
10.2.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 81
10.2.5 DIODE LASER 81
10.2.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 81
10.2.7 LITHIUM BORATE 81
10.2.8 OTHERS 81
10.3 BENIGN PROSTATIC HYPERPLASIA (BPH) 81
10.3.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 82
10.3.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 82
10.3.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 83
10.3.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 83
10.3.5 DIODE LASER 83
10.3.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 83
10.3.7 LITHIUM BORATE 83
10.3.8 OTHERS 83
10.4 PARTIAL KIDNEY RESECTION 83
10.4.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 84
10.4.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 84
10.4.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 84
10.4.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 84
10.4.5 DIODE LASER 84
10.4.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 85
10.4.7 LITHIUM BORATE 85
10.4.8 OTHERS 85
10.5 REMOVAL OF KIDNEY STONES 85
10.5.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 86
10.5.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 86
10.5.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 86
10.5.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 86
10.5.5 DIODE LASER 86
10.5.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 86
10.5.7 LITHIUM BORATE 87
10.5.8 OTHERS 87
10.6 URETHRAL STRICTURES 87
10.6.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 88
10.6.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 88
10.6.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 88
10.6.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 88
10.6.5 DIODE LASER 88
10.6.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 88
10.6.7 LITHIUM BORATE 89
10.6.8 OTHERS 89
10.7 TUMORS 89
10.7.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 90
10.7.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 90
10.7.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 90
10.7.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 90
10.7.5 DIODE LASER 90
10.7.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 90
10.7.7 LITHIUM BORATE 90
10.7.8 OTHERS 90
10.8 OTHERS 90
10.8.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 91
10.8.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 91
10.8.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 92
10.8.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 92
10.8.5 DIODE LASER 92
10.8.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 92
10.8.7 LITHIUM BORATE 92
10.8.8 OTHERS 92
11 GLOBAL UROLOGY LASER MARKET, BY END USER 93
11.1 OVERVIEW 94
11.2 HOSPITALS 97
11.3 UROLOGICAL CLINICS 97
11.4 AMBULATORY SURGICAL CENTERS 97
11.5 OTHERS 98
12 GLOBAL UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL 99
12.1 OVERVIEW 100
12.2 DIRECT TENDER 103
12.3 RETAIL SALES 103
12.4 ONLINE SALES 103
12.5 OTHERS 104
13 GLOBAL UROLOGY LASER MARKET, BY REGION 105
13.1 OVERVIEW 106
13.2 NORTH AMERICA 111
13.2.1 U.S. 115
13.2.2 CANADA 115
13.2.3 MEXICO 115
13.3 EUROPE 116
13.3.1 GERMANY 120
13.3.2 U.K. 120
13.3.3 ITALY 120
13.3.4 FRANCE 120
13.3.5 SPAIN 120
13.3.6 RUSSIA 120
13.3.7 SWITZERLAND 120
13.3.8 TURKEY 120
13.3.9 BELGIUM 120
13.3.10 NETHERLANDS 120
13.3.11 REST OF EUROPE 120
13.4 ASIA-PACIFIC 121
13.4.1 JAPAN 125
13.4.2 CHINA 125
13.4.3 SOUTH KOREA 125
13.4.4 INDIA 125
13.4.5 AUSTRALIA 125
13.4.6 SINGAPORE 125
13.4.7 THAILAND 125
13.4.8 INDONESIA 125
13.4.9 MALAYSIA 125
13.4.10 PHILIPPINES 125
13.4.11 REST OF ASIA-PACIFIC 125
13.5 SOUTH AMERICA 126
13.5.1 BRAZIL 130
13.5.2 ARGENTINA 130
13.5.3 COLOMBIA 130
13.5.4 PERU 130
13.5.5 CHILE 130
13.5.6 ECUADOR 130
13.5.7 URUGUAY 130
13.5.8 REST OF SOUTH AMERICA 130
13.6 MIDDLE EAST AND AFRICA 131
13.6.1 SOUTH AFRICA 135
13.6.2 SAUDI ARABIA 135
13.6.3 U.A.E. 135
13.6.4 ISRAEL 135
13.6.5 EGYPT 135
13.6.6 KUWAIT 135
13.6.7 QATAR 135
13.6.8 NIGERIA 135
13.6.9 REST OF MIDDLE EAST AND AFRICA 135
14 GLOBAL UROLOGY LASER MARKET, COMPANY LANDSCAPE 136
14.1 COMPANY SHARE ANALYSIS: GLOBAL 136
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 137
14.3 COMPANY SHARE ANALYSIS: EUROPE 138
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 139
15 SWOT ANALYSIS 140
16 COMPANY PROFILE 141
16.1 BOSTON SCIENTIFIC CORPORATION 141
16.1.1 COMPANY SNAPSHOT 141
16.1.2 REVENUE ANALYSIS 141
16.1.3 COMPANY SHARE ANALYSIS 142
16.1.4 PRODUCT PORTFOLIO 142
16.1.5 RECENT DEVELOPMENT 142
16.2 COOK 144
16.2.1 COMPANY SNAPSHOT 144
16.2.2 COMPANY SHARE ANALYSIS 144
16.2.3 PRODUCT PORTFOLIO 145
16.2.4 RECENT DEVELOPMENT 145
16.3 OLYMPUS CORPORATION 146
16.3.1 COMPANY SNAPSHOT 146
16.3.2 REVENUE ANALYSIS 146
16.3.3 COMPANY SHARE ANALYSIS 147
16.3.4 PRODUCT PORTFOLIO 147
16.3.5 RECENT DEVELOPMENT 147
16.4 COHERENT, INC. 148
16.4.1 COMPANY SNAPSHOT 148
16.4.2 REVENUE ANALYSIS 148
16.4.3 COMPANY SHARE ANALYSIS 149
16.4.4 PRODUCT PORTFOLIO 149
16.4.5 RECENT DEVELOPMENT 149
16.5 DORNIER MEDTECH 150
16.5.1 COMPANY SNAPSHOT 150
16.5.2 COMPANY SHARE ANALYSIS 150
16.5.3 PRODUCT PORTFOLIO 151
16.5.4 RECENT DEVELOPMENT 151
16.6 ADVIN HEALTH CARE 152
16.6.1 COMPANY SNAPSHOT 152
16.6.2 PRODUCT PORTFOLIO 152
16.6.3 RECENT DEVELOPMENTS 152
16.7 ALLENGERS 153
16.7.1 COMPANY SNAPSHOT 153
16.7.2 PRODUCT PORTFOLIO 153
16.7.3 RECENT DEVELOPMENT 153
16.8 BD 154
16.8.1 COMPANY SNAPSHOT 154
16.8.2 REVENUE ANALYSIS 154
16.8.3 PRODUCT PORTFOLIO 155
16.8.4 RECENT DEVELOPMENTS 155
16.9 BIOLITEC AG 156
16.9.1 COMPANY SNAPSHOT 156
16.9.2 PRODUCT PORTFOLIO 156
16.9.3 RECENT DEVELOPMENT 156

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.